Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Incidence and Duration of Unintentional Neuromodulation Effects After Pulmonary Vein Isolation in Patients With Atrial Fibrillation. (UNCOVER-PVI)

NCT05677516 is registered in ClinicalTrials.gov with 4th Military Clinical Hospital with Polyclinic, Poland as lead sponsor.

NCT NCT05677516
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05677516 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Incidence and Duration of Unintentional Neuromodulation Effects After Pulmonary Vein Isolation in Patients With Atrial Fibrillation. (UNCOVER-PVI)
Lead sponsor
4th Military Clinical Hospital with Polyclinic, Poland
Phase
Observational
Overall status
Unknown status
Start date
December 23, 2021
Completion date
December 23, 2023
Enrollment
100 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation